JP2016539190A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539190A5
JP2016539190A5 JP2016554939A JP2016554939A JP2016539190A5 JP 2016539190 A5 JP2016539190 A5 JP 2016539190A5 JP 2016554939 A JP2016554939 A JP 2016554939A JP 2016554939 A JP2016554939 A JP 2016554939A JP 2016539190 A5 JP2016539190 A5 JP 2016539190A5
Authority
JP
Japan
Prior art keywords
polypeptide
formula
group
heteroarylene
alkenylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016554939A
Other languages
English (en)
Japanese (ja)
Other versions
JP6609563B2 (ja
JP2016539190A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/066300 external-priority patent/WO2015079376A1/en
Publication of JP2016539190A publication Critical patent/JP2016539190A/ja
Publication of JP2016539190A5 publication Critical patent/JP2016539190A5/ja
Application granted granted Critical
Publication of JP6609563B2 publication Critical patent/JP6609563B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016554939A 2013-11-26 2014-11-24 ケトンで修飾されたポリペプチドをオキシム複合化する方法 Expired - Fee Related JP6609563B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361909236P 2013-11-26 2013-11-26
US61/909,236 2013-11-26
US201462002614P 2014-05-23 2014-05-23
US62/002,614 2014-05-23
PCT/IB2014/066300 WO2015079376A1 (en) 2013-11-26 2014-11-24 Methods for oxime conjugation to ketone-modified polypeptides

Publications (3)

Publication Number Publication Date
JP2016539190A JP2016539190A (ja) 2016-12-15
JP2016539190A5 true JP2016539190A5 (https=) 2018-01-18
JP6609563B2 JP6609563B2 (ja) 2019-11-20

Family

ID=52117931

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016554939A Expired - Fee Related JP6609563B2 (ja) 2013-11-26 2014-11-24 ケトンで修飾されたポリペプチドをオキシム複合化する方法

Country Status (15)

Country Link
US (1) US10172948B2 (https=)
EP (1) EP3074048B1 (https=)
JP (1) JP6609563B2 (https=)
KR (1) KR20160088429A (https=)
CN (1) CN105764530B (https=)
AU (1) AU2014356126B2 (https=)
CA (1) CA2928087A1 (https=)
EA (1) EA201691075A1 (https=)
ES (1) ES2729643T3 (https=)
IL (1) IL245244A0 (https=)
MX (1) MX2016006674A (https=)
TW (1) TWI572361B (https=)
UY (1) UY35854A (https=)
WO (1) WO2015079376A1 (https=)
ZA (1) ZA201602603B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2732574T3 (es) 2012-11-30 2019-11-25 Novartis Ag Métodos para preparar conjugados a partir de proteínas que contienen disulfuro
US10588980B2 (en) 2014-06-23 2020-03-17 Novartis Ag Fatty acids and their use in conjugation to biomolecules
KR102508023B1 (ko) 2014-09-03 2023-03-10 이뮤노젠 아이엔씨 세포-결합제 및 세포독성 약물을 포함하는 콘주게이트
US20190194315A1 (en) 2015-06-17 2019-06-27 Novartis Ag Antibody drug conjugates
WO2017051254A1 (en) * 2015-09-25 2017-03-30 Legochem Biosciences, Inc. Compositions and methods related to anti-egfr antibody drug conjugates
EP3355931B1 (en) 2015-10-01 2024-06-26 Novo Nordisk A/S Protein conjugates
EP3368092B9 (en) 2015-10-29 2020-07-29 Novartis AG Antibody conjugates comprising toll-like receptor agonist
AU2016359230B2 (en) 2015-11-25 2020-04-23 Ligachem Biosciences Inc. Conjugates comprising self-immolative groups and methods related thereto
AU2016359235B2 (en) 2015-11-25 2022-09-15 Ligachem Biosciences Inc. Antibody-drug conjugates comprising branched linkers and methods related thereto
JP7002733B2 (ja) * 2016-11-18 2022-02-04 国立大学法人 鹿児島大学 IgG結合ペプチドを含む固相担体及びIgGの分離方法
CA3058360A1 (en) 2017-03-29 2018-10-04 Legochem Biosciences, Inc. Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same
AR111651A1 (es) 2017-04-28 2019-08-07 Novartis Ag Conjugados de anticuerpos que comprenden agonistas del receptor de tipo toll y terapias de combinación
CN112601555A (zh) 2018-05-09 2021-04-02 乐高化学生物科学股份有限公司 与抗cd19抗体药物结合物相关的组合物和方法
SG11202100721SA (en) 2018-07-23 2021-02-25 Univ Alberta Genetically-encoded bicyclic peptide libraries
CA3120393A1 (en) * 2018-11-28 2020-06-04 The Governors Of The University Of Alberta Genetically-encoded macrocyclic peptide libraries bearing a pharmacophore
KR20210028544A (ko) 2019-09-04 2021-03-12 주식회사 레고켐 바이오사이언스 인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239110B1 (en) 1990-02-22 2001-05-29 W.R. Grace & Co. -Conn. Synthetic analogs of thrombospondin and therapeutic use thereof
WO1999013062A1 (en) 1997-09-09 1999-03-18 Nycomed Imaging As Factors vii fragments and analogs thereof and their use in the treatment of blood clotting disorders
WO1999013063A1 (en) 1997-09-09 1999-03-18 Nycomed Imaging As Factor vii fragments and analogs thereof and their use in the treatment of blood clottng disorders
GB0316294D0 (en) * 2003-07-11 2003-08-13 Polytherics Ltd Conjugated biological molecules and their preparation
US8673848B2 (en) * 2012-01-27 2014-03-18 Novartis Ag Synthetic apelin mimetics for the treatment of heart failure
US20090131306A1 (en) 2007-06-15 2009-05-21 Adherex Technologies, Inc. Chemically modified cyclic peptides containing cell adhesion recognition (car) sequences and uses therefor
US20110172126A1 (en) 2008-09-03 2011-07-14 Xenome Ltd Libraries of peptide conjugates and methods for making them
AU2010283632B2 (en) 2009-08-10 2016-08-25 Ucl Business Plc Reversible covalent linkage of functional molecules
CA2887129A1 (en) 2012-10-09 2014-04-17 Igenica, Inc. Anti-c16orf54 antibodies and methods of use thereof
JP6480340B2 (ja) 2012-11-15 2019-03-06 ブランデイズ ユニバーシティー 環状ジスルフィドを用いるシステイン残基のテザリング
ES2732574T3 (es) * 2012-11-30 2019-11-25 Novartis Ag Métodos para preparar conjugados a partir de proteínas que contienen disulfuro

Similar Documents

Publication Publication Date Title
JP2016539190A5 (https=)
CN111225918B (zh) 具有三环部分的Toll样受体7(TLR7)激动剂、其缀合物及其方法和用途
JP2018509394A5 (https=)
CN112261954B (zh) 具有针对抗体的亲和性物质和生物正交性官能团的化合物或其盐
US11505525B2 (en) Branched discrete PEG constructs
JP2021527040A (ja) カンプトテシンコンジュゲート
RU2015119561A (ru) Новые конъюгаты лекарственное вещество-белок
JP2015526434A5 (https=)
JP2020531466A (ja) 免疫刺激物質トル様受容体7(tlr7)アゴニストとしての6−アミノ−7,9−ジヒドロ−8h−プリン−8−オン誘導体
JP6609563B2 (ja) ケトンで修飾されたポリペプチドをオキシム複合化する方法
JP2017503011A5 (https=)
JP2016512425A5 (https=)
EP3668869A1 (en) 6-amino-7,9-dihydro-8h-purin-8-one derivatives as toll-like receptor 7 (tlr7) agonists as immunostimulants
JP2019043957A5 (https=)
RU2015146614A (ru) Конъюгированная вакцина на основе пептида антигена wt1
JP2012518029A5 (https=)
JP2017504606A5 (https=)
TW201920180A (zh) 具苯并三唑部分之類鐸受體7(tlr7)促效劑,其結合物及其方法及用途
JP2018510864A5 (https=)
JP2023010733A (ja) γ-アマニチンの誘導体
JP2016153410A5 (https=)
WO2015118031A2 (en) Antibody-drug conjugates and immunotoxins
JP2014516991A5 (https=)
CA2653941A1 (en) Substituted amino purine derivatives and uses thereof
WO2015118030A2 (en) Antibody-drug conjugates and immunotoxins